» Articles » PMID: 17185424

Quick Identification of Febrile Neonates with Low Risk for Serious Bacterial Infection: an Observational Study

Overview
Date 2006 Dec 23
PMID 17185424
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the possible usefulness of simple and quick criteria for identifying febrile neonates with low risk for serious bacterial infection (SBI).

Design: All febrile neonates who were admitted between August 1998 and August 2003 to the Pediatric Emergency Department, HaEmek Medical Center, Afula, Israel, and to the Poriya Hospital, Tiberias, Israel, were included in the study. The recommended evaluation of each neonate included details of medical history and a complete physical examination, including blood culture, erythrocyte sedimentation rate (ESR), white cell count (WBC), and analysis and culture of urine and cerebrospinal fluid. Other tests were carried out as necessary. Patients who met all the following criteria were considered to have low risk for SBI: (1) unremarkable medical history; (2) good appearance; (3) no focal physical signs of infection; (4) ESR <30 mm at the end of the first hour; (5) WBC 5000-15 000/mm(3); (6) a normal urine analysis by the dipstick method.

Results: Complete data were available for 386 neonates. SBI was documented in 108 (28%) neonates, of whom 14% had a urinary tract infection, 9.3% had acute otitis media, 2.3% had pneumonia, 1.3% had cellulitis, 0.5% had bacterial meningitis and 0.5% had bacterial gastroenteritis. The overall incidence of SBI was 1 in 166 (0.6%) neonates who fulfilled the criteria compared with 107 in 220 (48.6%) in the neonates who did not fulfil the criteria (p<0.001). The negative predictive value for SBI of the combination of the low-risk criteria was 99.4% (95% confidence interval 99.35% to 99.45%).

Conclusions: Fulfillment of the criteria for low risk might be a reliable and useful tool for excluding SBI in febrile neonates.

Citing Articles

Delta Neutrophil Index Does Not Differentiate Bacterial Infection without Bacteremia from Viral Infection in Pediatric Febrile Patients.

Kim M, Lee J, Kwak Y, Kim H, Kwon H, Suh D Children (Basel). 2023; 10(1).

PMID: 36670711 PMC: 9857165. DOI: 10.3390/children10010161.


Cost Analysis of Emergency Department Criteria for Evaluation of Febrile Infants Ages 29 to 90 Days.

Coyle C, Brock G, Wallihan R, Leonard J J Pediatr. 2020; 231:94-101.e2.

PMID: 33130155 PMC: 8005434. DOI: 10.1016/j.jpeds.2020.10.033.


Variability in Hospital Admission Rates for Neonates With Fever in North Carolina.

Wu W, Harmon K, Waller A, Mann C Glob Pediatr Health. 2019; 6:2333794X19865447.

PMID: 31384632 PMC: 6659181. DOI: 10.1177/2333794X19865447.


Assessment of febrile neonates according to low risk criteria for serious bacterial infection.

Zarkesh M, Hashemian H, Momtazbakhsh M, Rostami T Iran J Pediatr. 2012; 21(4):436-40.

PMID: 23056828 PMC: 3446129.


Is there a place for "drive thru" management of neonatal fever? Not yet!.

Rudd P Arch Dis Child Fetal Neonatal Ed. 2006; 92(1):F2-3.

PMID: 17185426 PMC: 2675291. DOI: 10.1136/adc.2006.100560.

References
1.
Gorelick M, SHAW K . Screening tests for urinary tract infection in children: A meta-analysis. Pediatrics. 1999; 104(5):e54. DOI: 10.1542/peds.104.5.e54. View

2.
Kadish H, Loveridge B, Tobey J, Bolte R, Corneli H . Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered?. Clin Pediatr (Phila). 2000; 39(2):81-8. DOI: 10.1177/000992280003900202. View

3.
Herr S, Wald E, Pitetti R, Choi S . Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness. Pediatrics. 2001; 108(4):866-71. DOI: 10.1542/peds.108.4.866. View

4.
McIntosh K . Community-acquired pneumonia in children. N Engl J Med. 2002; 346(6):429-37. DOI: 10.1056/NEJMra011994. View

5.
Turner D, Leibovitz E, Aran A, Piglansky L, Raiz S, Leiberman A . Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J. 2002; 21(7):669-74. DOI: 10.1097/00006454-200207000-00013. View